ST-41517

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameST-41517
Drug Alias NameST-41517
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnadys Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnadys Pharmaceuticals IncUniversity Of Massachusetts Medical School
Active IndicationsN/A
Inactive IndicationsMycoses

Other Information

ATC CodeN/A
Related LinksN/A